Table 1.
The patients' underlying connective tissue diseases.
| Denosumab group |
Teriparatide group |
|
|---|---|---|
| Disease | n = 24 | n = 23 |
| Polymyositis, dermatomyositis | 3 | 8 |
| Systemic lupus erythematosus | 7 | 3 |
| Rheumatoid arthritis | 5 | 2 |
| Polymyalgia rheumatica | 3 | 1 |
| ANCA-associated vasculitis | 3 | 1 |
| Systemic sclerosis | 1 | 3 |
| Overlap syndrome | 1 | 0 |
| RS3PE syndrome | 1 | 0 |
| Sjögren syndrome | 0 | 1 |
| Mixed connective tissue disease | 0 | 1 |
| Takayasu arteritis | 0 | 1 |
| Polyarteritis nodosa | 0 | 1 |
| Spondyloarthritis | 0 | 1 |
Antineutrophil cytoplasmic antibody; ANCA.
RS3PE; Remitting Seronegative Symmetrical Synovitis with Pitting Edema.